{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:02Z","timestamp":1786986842859,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.clindermatol.2009.03.005","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T05:22:17Z","timestamp":1260940937000},"page":"24-30","source":"Crossref","is-referenced-by-count":59,"title":["The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies"],"prefix":"10.1016","volume":"28","author":[{"given":"Dimitris","family":"Rigopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Larios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas D.","family":"Katsambas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2009.03.005_bib1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6171.1109","article-title":"Prevalence of facial acne vulgaris in late adolescence and in adults","volume":"1","author":"Cunliffe","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000067817","article-title":"Epidemiology of acne","volume":"206","author":"Dreno","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1440-0960.1997.tb01126.x","article-title":"Descriptive epidemiology of acne vulgaris in the community","volume":"38","author":"Stathakis","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2133.1971.tb07195.x","article-title":"The prevalence of acne vulgaris in adolescence","volume":"85","author":"Burton","year":"1971","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib5","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0190-9622(98)70442-6","article-title":"Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris","volume":"39","author":"White","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 4","key":"10.1016\/j.clindermatol.2009.03.005_bib6","first-page":"3","article-title":"Psychosocial effects of acne","volume":"8","author":"Thomas","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib7","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/0190-9622(95)90417-4","article-title":"The psychosocial impact of acne: patients\u2019 perceptions","volume":"32","author":"Koo","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1529-8019.2006.00079.x","article-title":"Psychological problems in the acne patient","volume":"19","author":"Fried","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib9","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(98)01046-0","article-title":"Acne vulgaris","volume":"351","author":"Brown","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jama.292.6.726","article-title":"Treatment of acne vulgaris","volume":"292","author":"Haider","year":"2004","journal-title":"JAMA."},{"key":"10.1016\/j.clindermatol.2009.03.005_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.325.7362.475","article-title":"Acne vulgaris","volume":"325","author":"Webster","year":"2002","journal-title":"BMJ"},{"issue":"1 suppl","key":"10.1016\/j.clindermatol.2009.03.005_bib12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00403-008-0879-5","article-title":"The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne","volume":"300","author":"Zouboulis","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000017874","article-title":"The pilosebaceous unit is part of the skin immune system","volume":"196","author":"B\u00f6hm","year":"1998","journal-title":"Dermatology"},{"issue":"suppl 3","key":"10.1016\/j.clindermatol.2009.03.005_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0926-9959.2001.00012.x","article-title":"The integral role of topical and oral retinoids in the early treatment of acne","volume":"15","author":"Shalita","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clindermatol.2004.03.004","article-title":"Acne and sebaceous gland function","volume":"22","author":"Zouboulis","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.0906-6705.2005.0285a.x","article-title":"What is the pathogenesis of acne?","volume":"14","author":"Zouboulis","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12321.x","article-title":"Inflammatory events are involved in acne lesion initiation","volume":"121","author":"Jeremy","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0095-4543(05)70196-2","article-title":"Pearls in the management of acne: an advanced approach","volume":"27","author":"Usatine","year":"2000","journal-title":"Prim Care"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128072-200305050-00003","article-title":"Guidelines for the management of acne vulgaris in adolescents","volume":"5","author":"Goulden","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1540-9740.2003.02134.x","article-title":"Assessment of etiologic agents in acne pathogenesis","volume":"2","author":"Burkhart","year":"2003","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000246876","article-title":"Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans","volume":"189","author":"Karvonen","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.2005.06933.x","article-title":"Induction of toll-like receptors by Propionibacterium acnes","volume":"153","author":"Jugeau","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.clindermatol.2004.03.002","article-title":"Guidelines for treating acne","volume":"22","author":"Katsambas","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1346-8138.2008.00463.x","article-title":"Evaluation of the newly established acne severity classification among Japanese and Korean dermatologists","volume":"35","author":"Hayashi","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.1979.04010050005003","article-title":"An acne grading method using photographic standards","volume":"115","author":"Cook","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib27","first-page":"2123","article-title":"Diagnosis and treatment of acne","volume":"69","author":"Feldman","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0190-9622(08)80076-X","article-title":"Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990","volume":"24","author":"Pochi","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0190-9622(93)70076-6","article-title":"Acne fulminans: report of clinical findings and treatment of twenty-four patients","volume":"28","author":"Karvonen","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2133.1999.02982.x","article-title":"The treatment of acne fulminans: a review of 25 cases","volume":"141","author":"Seukeran","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib31","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00105-005-1031-5","article-title":"[Clinical variants of acne]","volume":"56","author":"Jansen","year":"2005","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib32","first-page":"1","article-title":"Pathogenesis of acne: recent research advances","volume":"19","author":"Harper","year":"2003","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1529-8019.2008.00175.x","article-title":"New and emerging treatments in dermatology: acne","volume":"21","author":"Katsambas","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0190-9622(96)90462-4","article-title":"Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings","volume":"34","author":"Geiger","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib35","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/sj.jid.5700418","article-title":"Isotretinoin revisited: pluripotent effects on human sebaceous gland cells","volume":"126","author":"Zouboulis","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib36","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/sj.jid.5700289","article-title":"13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes","volume":"126","author":"Nelson","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1440-0960.2003.00653.x","article-title":"Treatment of acne with isotretinoin: recommendations based on Australian experience","volume":"44","author":"Cooper","year":"2003","journal-title":"Australas J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2009.03.005_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000246012","article-title":"Does oral isotretinoin prevent Propionibacterium acnes resistance?","volume":"195","author":"Coates","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib39","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1365-2133.2005.06897.x","article-title":"Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne","volume":"153","author":"Coates","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF00372055","article-title":"The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin","volume":"28","author":"Wozel","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.0022-202X.2005.23848.x","article-title":"Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin","volume":"125","author":"Papakonstantinou","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib42","series-title":"Accutane (isotretinoin) capsules: complete product information [package insert]","year":"2007"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2006.01671.x","article-title":"A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris","volume":"20","author":"Layton","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib44","first-page":"565","article-title":"An expert view on the treatment of acne with systemic antibiotics and\/or oral isotretinoin in the light of the new European recommendations","volume":"16","author":"Dr\u00e9no","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00128071-200304040-00005","article-title":"Treatment of gram-negative folliculitis in patients with acne","volume":"4","author":"B\u00f6ni","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00407743","article-title":"Treatment of gram-negative folliculitis with isotretinoin","volume":"278","author":"Neubert","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/j.1552-4604.1983.tb01800.x","article-title":"Food increases the bioavailability of isotretinoin","volume":"23","author":"Colburn","year":"1983","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib48","first-page":"878","article-title":"Oral isotretinoin for acne, adjusting treatment according to patient's response","volume":"5","author":"Ghaffarpour","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1529-8019.2006.00084.x","article-title":"Update in retinoid therapy of acne","volume":"19","author":"Thielitz","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib50","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0190-9622(08)80252-6","article-title":"Guidelines for optimal use of isotretinoin in acne","volume":"27","author":"Layton","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000017848","article-title":"Oral retinoids in the treatment of seborrhoea and acne","volume":"196","author":"Orfanos","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2133.1993.tb11849.x","article-title":"Isotretinoin for acne vulgaris\u201310 years later: a safe and successful treatment","volume":"129","author":"Layton","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clindermatol.2004.03.014","article-title":"Acne: systemic treatment","volume":"22","author":"Katsambas","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000246134","article-title":"Roaccutane treatment guidelines: results of an international survey","volume":"194","author":"Cunliffe","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000247311","article-title":"Isotretinoin: 10 years on","volume":"186","author":"Harms","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-3083.1998.tb00763.x","article-title":"Medium dose isotretinoin for the treatment of acne","volume":"11","author":"Hermes","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000247322","article-title":"Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years","volume":"186","author":"Lehucher-Ceyrac","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2133.1997.tb03710.x","article-title":"Treatment of acne with intermittent isotretinoin","volume":"137","author":"Goulden","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib59","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1468-3083.2006.01784.x","article-title":"The effectiveness of intermittent isotretinoin treatment in mild or moderate acne","volume":"20","author":"Kaymak","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib60","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib61","first-page":"41","article-title":"Low-dose schema of isotretinoin in acne vulgaris","volume":"23","author":"Mandekou-Lefaki","year":"2003","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib62","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1046\/j.1365-2303.2003.00108.x-i1","article-title":"Very low dose isotretinoin is effective in controlling seborrhea","volume":"1","author":"Geissler","year":"2003","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib63","series-title":"Dermatology e-dition","article-title":"Retinoids","author":"Kuenzli","year":"2008"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2009.03.005_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000246018","article-title":"Oral isotretinoin treatment policy. Do we all agree?","volume":"195","author":"Ortonne","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000249320","article-title":"The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study","volume":"172","author":"Harms","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1993.tb11850.x","article-title":"Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course?","volume":"129","author":"Stainforth","year":"1993","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2009.03.005_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000246017","article-title":"Oral isotretinoin. How can we treat difficult acne patients?","volume":"195","author":"Leyden","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib68","first-page":"4","article-title":"Safe use of acne drug.","volume":"39","author":"[No authors listed]","year":"2005","journal-title":"FDA Consum"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib69","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1067\/mjd.2001.113717","article-title":"Uses and complications of isotretinoin therapy","volume":"45","author":"Ellis","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib70","first-page":"273","article-title":"Adverse effects of retinoids","volume":"3","author":"David","year":"1988","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib71","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0190-9622(84)80142-5","article-title":"Isotretinoin and pregnancy","volume":"10","author":"Stern","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib72","first-page":"28","article-title":"Accutane-exposed pregnancies\u2013California, 1999","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14740338.3.2.119","article-title":"Safety and side effects of the acne drug, oral isotretinoin","volume":"3","author":"Charakida","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib74","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/000155501317140070","article-title":"Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin","volume":"81","author":"Landau","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib75","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1067\/mjd.2001.113719","article-title":"Analysis of common side effects of isotretinoin","volume":"45","author":"McLane","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib76","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaad.2004.02.012","article-title":"American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations","volume":"50","author":"Goldsmith","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib77","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2004.04.032","article-title":"Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne","volume":"51","author":"DiGiovanna","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib78","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1067\/mjd.2001.118233","article-title":"Suicide, depression, and isotretinoin: is there a causal link?","volume":"45","author":"Jacobs","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib79","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib80","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sder.2008.03.005","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"26","author":"Marqueling","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09546630410020325","article-title":"The moral of the isotretinoin depression story","volume":"15","author":"Feldman","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib82","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.euroneuro.2005.11.006","article-title":"Increased use of mental health services related to isotretinoin treatment: a 5-year analysis","volume":"16","author":"Friedman","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib83","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.det.2005.05.008","article-title":"Acne, depression, and suicide","volume":"23","author":"Hull","year":"2005","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib84","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00128071-200304070-00005","article-title":"Isotretinoin use and subsequent depression and suicide: presenting the evidence","volume":"4","author":"Hull","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib85","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1345\/aph.1C415","article-title":"Isotretinoin and psychiatric illness in adolescents and young adults","volume":"37","author":"Enders","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib86","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clpt.2004.01.003","article-title":"The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone","volume":"75","author":"Hendrix","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00128071-200506010-00004","article-title":"Medication-induced intracranial hypertension in dermatology","volume":"6","author":"Friedman","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2009.03.005_bib88","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1468-3083.2007.02162.x","article-title":"Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?","volume":"21","author":"Verros","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X09000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T03:27:53Z","timestamp":1710732473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X09000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0738081X09000510"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2009.03.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}